Please Wait
Applying Filters...
menu
    • menu
    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Daratumumab

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 9Darzalex

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Darzalex

    Daratumumab

    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Brand Name : Darzalex

    U.S.A
    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Johnson & Johnson

    Daratumumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2020 Revenue in Millions : 4,190

    2019 Revenue in Millions : 2,998

    Growth (%) : 40

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Darzalex

    Daratumumab

    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Brand Name : Darzalex

    U.S.A
    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Johnson & Johnson

    Daratumumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2021 Revenue in Millions : 6,023

    2020 Revenue in Millions : 4,190

    Growth (%) : 44

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Darzalex

    Daratumumab

    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Brand Name : Darzalex

    U.S.A
    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Johnson & Johnson

    Daratumumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2022 Revenue in Millions : 7,977

    2021 Revenue in Millions : 6,023

    Growth (%) : 32

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Darzalex

    Daratumumab

    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Brand Name : Darzalex

    U.S.A
    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Johnson & Johnson

    Daratumumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2023 Revenue in Millions : 9,744

    2022 Revenue in Millions : 7,977

    Growth (%) : 22

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Darzalex

    Daratumumab

    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Brand Name : Darzalex

    U.S.A
    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Johnson & Johnson

    Daratumumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2024 Revenue in Millions : 11,670

    2023 Revenue in Millions : 9,744

    Growth (%) : 20

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Darzalex

    Daratumumab

    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Brand Name : Darzalex

    U.S.A
    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Johnson & Johnson

    Daratumumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2016 Revenue in Millions : 572

    2015 Revenue in Millions : 20

    Growth (%) : 2,760

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Darzalex

    Daratumumab

    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Brand Name : Darzalex

    U.S.A
    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Johnson & Johnson

    Daratumumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2017 Revenue in Millions : 1,242

    2016 Revenue in Millions : 572

    Growth (%) : 117

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Darzalex

    Daratumumab

    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Brand Name : Darzalex

    U.S.A
    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Johnson & Johnson

    Daratumumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2018 Revenue in Millions : 2,025

    2017 Revenue in Millions : 1,242

    Growth (%) : 63%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Darzalex

    Daratumumab

    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Brand Name : Darzalex

    U.S.A
    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Johnson & Johnson

    Daratumumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2019 Revenue in Millions : 2,998

    2018 Revenue in Millions : 2,025

    Growth (%) : 48

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF